Related Experiment Video
Updated: Sep 15, 2025

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
Published on: October 4, 2024
Effectiveness of Multisymptom Support for Better Relief and Alleviation of Common Effects in Perimenopause (EMBRACE
Reena Choudhury1, Kiran Coelho2, Sachin Suryawanshi3
1General Medicine, Redkar Hospital and Research Center, Goa, IND.
Background:
Menopause affects 1.5 million women annually, with perimenopause lasting 2-8 years and causing symptoms like hot flashes, sleep disturbances, mood changes, and joint pain. While hormone replacement therapy (HRT) is effective, safety concerns limit its use, leading many women to seek nonhormonal alternatives. Nutraceuticals such as ashwagandha, vitex, and black cohosh offer potential benefits, with 80% of women using supplements. This study evaluates the efficacy and safety of Arth perimenopause multisymptom capsules, providing evidence for nutraceuticals as an alternative to HRT.
Methodology:
The Effectiveness of Multisymptom Support for Better Relief and Alleviation of Common Effects in Perimenopause (EMBRACE PERIMENOPAUSE) study was a prospective, observational trial conducted at Redkar Hospital and Research Center, Goa. Thirty perimenopausal women aged 40-48 years with irregular menstrual cycles and at least two menopausal symptoms received one Arth capsule daily for 60 days. Using standardized case report forms, data were collected at screening, baseline, and days 7, 15, 30, and 60. Primary outcomes included changes in menopausal symptoms (Menopause Rating Scale (MRS)), reduction in daily hot flashes, and improvement in breast tenderness. Secondary outcomes assessed the quality of life (QoL), changes in hair and skin texture, patient and physician global assessments, and intervention tolerability. Statistical analyses included Chi-square tests and analysis of variance (ANOVA) (p < 0.05).
Results:
At baseline, 100% of patients reported hot flashes, followed by irritability (90%) and night sweating (83%). The mean MRS score decreased from 39 at baseline to 2.74 by day 60 (-92.97%, p < 0.01). By day 60, 93% of patients achieved complete resolution of hot flashes, 88% for sweating, 91% for anxiety, and 90% for depressive mood (p < 0.05). Overall, treatment significantly improved menopausal symptoms, QoL, and patient satisfaction.
Conclusion:
Arth Perimenopause Multisymptom Support capsules demonstrated significant efficacy in alleviating perimenopausal symptoms while improving QoL. This nonhormonal, well-tolerated nutraceutical represents a promising alternative for managing perimenopause-related discomfort.
More Related Videos
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
Related Concept Videos
Menopause
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Stress Prevention and Stress Management Techniques V
Stress Prevention and Stress Management Techniques III
The Role of Exercise in Stress Management
Regular physical activity is essential for reducing stress and promoting cardiovascular health. Exercise strengthens the heart, enhances blood flow, keeps blood vessels flexible, and helps lower blood pressure, all of which reduce the body's stress response. Research shows that adults who exercise regularly have nearly half the...
Coping Strategies: Emotion Focused
Acute Coronary Syndrome IV: Interprofessional Care